Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Robert Dempsey
Person

Robert Dempsey

Tracked across 1 events · 7 articles · First seen Jan 30, 2026 · Last active Jan 30, 2026

Sentiment
30
Attention
2
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 30
Business
OKYO Pharma Urcosimod Abstract Accepted
As CEO of OKYO Pharma, Robert Dempsey expressed delight regarding the acceptance of urcosimod's Phase 2 data for presentation, emphasizing its potential as a novel therapeutic for neuropathic corneal pain.
Jan 30, 2026 · 7 articles
Relationships (1)
OKYO Pharma Chief Executive Officer ↔ Robert Dempsey Robert Dempsey is the Chief Executive Officer of OKYO Pharma.
NEWSDESK
Track Robert Dempsey live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.